News
A study published in The Annals of Family Medicine examined if gaining housing increased rates of colorectal and breast ...
Scientists have made a major breakthrough in treating breast cancer by removing the building blocks that allow the killer ...
A month after Cassandra finished chemotherapy, in June 2023, her younger sister Katelyn was diagnosed with the same type of ...
At a stroke, the data gives Celcuity a potential advantage over already-marketed oral PI3K inhibitors like Novartis' ...
A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Explore more
Breast cancer rates among women are on the rise, and doctors are pointing to alcohol as a potential contributing factor.
Celcuity said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer in a late-stage study, sending the biotech firm's shares surging to a record ...
Celcuity’s stock jumps after Phase 3 trial shows gedatolisib slashes progression risk in breast cancer patients by up to 76%.
There’s overwhelming community support for a beloved Montgomery County restaurant owner fighting Stage 4 breast cancer.
Breast cancer rates are on the rise, and doctors fear that alcohol could be a big reason why. CNN’s Meg Tirrell speaks to an ...
Bone health management varies across hospitals for older women with early breast cancer who have inconsistent bone density ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results